2020 Q3 Form 10-Q Financial Statement

#000137367020000062 Filed on October 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $275.8M $230.1M $209.4M
YoY Change 31.72% 24.3% 37.72%
Cost Of Revenue $207.9M $181.4M $164.7M
YoY Change 26.27% 41.06% 42.72%
Gross Profit $67.89M $48.70M $44.73M
YoY Change 51.79% 31.66% 21.97%
Gross Profit Margin 24.61% 21.16% 21.36%
Selling, General & Admin $29.18M $27.60M $25.06M
YoY Change 16.42% -30.83% 27.58%
% of Gross Profit 42.98% 56.67% 56.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $920.0K $640.0K $760.0K
YoY Change 21.05% -43.86% 0.0%
% of Gross Profit 1.36% 1.31% 1.7%
Operating Expenses $29.18M $30.70M $25.06M
YoY Change 16.42% -26.2% 27.58%
Operating Profit $38.71M $18.00M $19.66M
YoY Change 96.85% -490.29% 17.9%
Interest Expense $5.300M $2.200M $3.000M
YoY Change 76.67% 214.29% 11.11%
% of Operating Profit 13.69% 12.22% 15.26%
Other Income/Expense, Net $2.125M $2.300M $3.778M
YoY Change -43.75% -1250.0% 940.77%
Pretax Income $45.92M $22.60M $24.97M
YoY Change 83.9% 9.18% 24.2%
Income Tax $10.00M $5.000M $5.800M
% Of Pretax Income 21.78% 22.12% 23.23%
Net Earnings $34.82M $15.90M $15.67M
YoY Change 122.19% 19.07% 28.48%
Net Earnings / Revenue 12.62% 6.91% 7.48%
Basic Earnings Per Share $0.69 $0.31
Diluted Earnings Per Share $0.68 $314.2K $0.31
COMMON SHARES
Basic Shares Outstanding 50.62M shares 50.49M shares 50.48M shares
Diluted Shares Outstanding 50.88M shares 50.60M shares

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.30M $33.30M $35.10M
YoY Change 14.81% -13.05% 6.04%
Cash & Equivalents $40.27M $33.27M $41.23M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $779.4M $753.6M $740.8M
Prepaid Expenses
Receivables $5.700M $4.700M $9.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $825.4M $791.6M $785.4M
YoY Change 5.09% 11.16% 14.59%
LONG-TERM ASSETS
Property, Plant & Equipment $3.620M $4.309M $4.192M
YoY Change -13.65% -8.12% -0.21%
Goodwill $680.0K $680.0K $680.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles $643.0K $707.0K $728.0K
YoY Change -11.68% -17.41% -30.07%
Long-Term Investments $46.24M $30.29M $24.44M
YoY Change 89.15% 49.46% 17.49%
Other Assets $26.00M $19.70M $21.90M
YoY Change 18.72% -1.01% -31.56%
Total Long-Term Assets $119.2M $83.94M $80.39M
YoY Change 48.26% 16.7% -6.11%
TOTAL ASSETS
Total Short-Term Assets $825.4M $791.6M $785.4M
Total Long-Term Assets $119.2M $83.94M $80.39M
Total Assets $944.6M $875.5M $865.8M
YoY Change 9.1% 11.67% 12.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.10M $30.00M $34.70M
YoY Change -33.43% 14.94% -0.86%
Accrued Expenses $52.70M $28.20M $35.00M
YoY Change 50.57% -3.42% 48.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $105.1M $82.20M $96.80M
YoY Change 8.57% -5.84% 4.76%
LONG-TERM LIABILITIES
Long-Term Debt $220.3M $251.7M $250.4M
YoY Change -12.02% 20.49% 20.44%
Other Long-Term Liabilities $200.0K $5.300M $2.100M
YoY Change -90.48% 140.91% 320.0%
Total Long-Term Liabilities $220.5M $257.0M $252.5M
YoY Change -12.67% 21.74% 21.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $105.1M $82.20M $96.80M
Total Long-Term Liabilities $220.5M $257.0M $252.5M
Total Liabilities $312.1M $325.5M $337.1M
YoY Change -7.42% 12.31% 15.05%
SHAREHOLDERS EQUITY
Retained Earnings $320.3M $235.0M $220.3M
YoY Change 45.44% 32.39% 34.17%
Common Stock $292.9M $291.3M $291.6M
YoY Change 0.44% -0.17% 0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.167M $3.167M $3.167M
YoY Change 0.0% 222.83%
Treasury Stock Shares
Shareholders Equity $610.1M $523.2M $508.7M
YoY Change
Total Liabilities & Shareholders Equity $944.6M $875.5M $865.8M
YoY Change 9.1% 11.67% 12.29%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $34.82M $15.90M $15.67M
YoY Change 122.19% 19.07% 28.48%
Depreciation, Depletion And Amortization $920.0K $640.0K $760.0K
YoY Change 21.05% -43.86% 0.0%
Cash From Operating Activities $25.09M -$820.0K -$450.0K
YoY Change -5675.56% -28.7% -98.27%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K -$730.0K -$700.0K
YoY Change -24.29% -49.31% 18.64%
Acquisitions
YoY Change
Other Investing Activities -$9.860M -$5.300M $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.38M -$6.030M -$700.0K
YoY Change 1382.86% 315.86% -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.18M 3.310M 3.520M
YoY Change -531.25% -601.52% -88.98%
NET CHANGE
Cash From Operating Activities 25.09M -820.0K -450.0K
Cash From Investing Activities -10.38M -6.030M -700.0K
Cash From Financing Activities -15.18M 3.310M 3.520M
Net Change In Cash -470.0K -3.540M 2.370M
YoY Change -119.83% 8.59% -37.8%
FREE CASH FLOW
Cash From Operating Activities $25.09M -$820.0K -$450.0K
Capital Expenditures -$530.0K -$730.0K -$700.0K
Free Cash Flow $25.62M -$90.00K $250.0K
YoY Change 10148.0% -131.03% -100.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001373670
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15262000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
643000 USD
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51053858 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50661919 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50488010 shares
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y3M
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33530
dei Entity Registrant Name
EntityRegistrantName
Green Brick Partners, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5952523
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75093
dei Entity Address Address Line1
EntityAddressAddressLine1
2805 Dallas Pkwy
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
dei City Area Code
CityAreaCode
(469)
dei Local Phone Number
LocalPhoneNumber
573-6755
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
GRBK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50661919 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40269000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33269000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
10580000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
4416000 USD
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
5651000 USD
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4720000 USD
CY2020Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
779360000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
753567000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
46235000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
30294000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2800000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3462000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3620000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4309000 USD
CY2020Q3 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
22263000 USD
CY2019Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
14686000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15377000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
707000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
680000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
680000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
17104000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
10167000 USD
CY2020Q3 us-gaap Assets
Assets
944582000 USD
CY2019Q4 us-gaap Assets
Assets
875539000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
23127000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
30044000 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
49847000 USD
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24656000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29339000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23954000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2888000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3564000 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
93489000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
164642000 USD
CY2020Q3 us-gaap Senior Notes
SeniorNotes
111028000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
73406000 USD
CY2020Q3 us-gaap Other Notes Payable
OtherNotesPayable
2131000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
0 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
210000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
312059000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
325533000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
13624000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
13611000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
511000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
292388000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
290799000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
320347000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235027000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
610079000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
523168000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
8820000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
13227000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
618899000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
536395000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
944582000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
875539000 USD
CY2020Q3 us-gaap Revenues
Revenues
275821000 USD
CY2019Q3 us-gaap Revenues
Revenues
209404000 USD
us-gaap Revenues
Revenues
721921000 USD
us-gaap Revenues
Revenues
561538000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
207935000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
164679000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
551171000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
441166000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
67886000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
44725000 USD
us-gaap Gross Profit
GrossProfit
170750000 USD
us-gaap Gross Profit
GrossProfit
120372000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29177000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25061000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81718000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70584000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
210000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1492000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1749000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5299000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3022000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13038000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7565000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2125000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3778000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3004000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6143000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45923000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24972000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104864000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
61747000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9969000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5833000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17357000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14993000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
35954000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
19139000 USD
us-gaap Profit Loss
ProfitLoss
87507000 USD
us-gaap Profit Loss
ProfitLoss
46754000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1135000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3468000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3124000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4018000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34819000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15671000 USD
us-gaap Net Income Loss
NetIncomeLoss
84383000 USD
us-gaap Net Income Loss
NetIncomeLoss
42736000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50617000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50475000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50552000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50564000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50876000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50597000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50739000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50642000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51053858 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
511000 USD
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
292887000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
320347000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
285528000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
575759000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
8186000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
583945000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34819000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34819000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
634000 USD
CY2020Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
35453000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51053858 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
511000 USD
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
292388000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
610079000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
8820000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
618899000 USD
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2019Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
183938 shares
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1369000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
289739000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
204591000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
493470000 USD
CY2019Q2 us-gaap Minority Interest
MinorityInterest
5173000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
498643000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
73000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
73000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
208001 shares
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1798000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1798000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1798000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15671000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15671000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
2605000 USD
CY2019Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
18276000 USD
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220262000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
508715000 USD
CY2019Q3 us-gaap Minority Interest
MinorityInterest
7778000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516493000 USD
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
290799000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235027000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
523168000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
13227000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
536395000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
249617 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1601000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1601000 USD
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
75708 shares
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
592000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
592000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
357000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
357000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
357000 USD
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
225000 USD
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
225000 USD
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
937000 USD
CY2020Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
400000 USD
CY2020Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
400000 USD
CY2020Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
400000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5251000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5251000 USD
us-gaap Net Income Loss
NetIncomeLoss
84383000 USD
us-gaap Net Income Loss
NetIncomeLoss
84383000 USD
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
1381000 USD
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
85764000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51053858 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
511000 USD
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
292388000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
320347000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
610079000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
8820000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
618899000 USD
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50719884 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
136756 shares
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
981000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291299000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
177526000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
468351000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
17281000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
485632000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
215000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
215000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
215000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
219181 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1466000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1466000 USD
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
59116 shares
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
255183 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2186000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2186000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2186000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10993000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10993000 USD
us-gaap Net Income Loss
NetIncomeLoss
42736000 USD
us-gaap Net Income Loss
NetIncomeLoss
42736000 USD
us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
1490000 USD
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
44226000 USD
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291111000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220262000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
508715000 USD
CY2019Q3 us-gaap Minority Interest
MinorityInterest
7778000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516493000 USD
us-gaap Profit Loss
ProfitLoss
87507000 USD
us-gaap Profit Loss
ProfitLoss
46754000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2461000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2443000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1958000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2035000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1749000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-115000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
706000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13038000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7565000 USD
grbk Earnest Money Depositsand Preacquisition Costs Written Off
EarnestMoneyDepositsandPreacquisitionCostsWrittenOff
1490000 USD
grbk Earnest Money Depositsand Preacquisition Costs Written Off
EarnestMoneyDepositsandPreacquisitionCostsWrittenOff
520000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7444000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3390000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
931000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4668000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25263000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71392000 USD
us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
9067000 USD
us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
-860000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6951000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
623000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-6917000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8599000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25191000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2141000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
5267000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1332000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5385000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4856000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
64097000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21239000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10347000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1707000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1838000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12054000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1838000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
217500000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
165500000 USD
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
37500000 USD
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
75000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
289000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
201500000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10715000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
8584000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
62000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1682000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
514000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
592000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2186000 USD
grbk Contributionsof Llc Members
ContributionsofLLCMembers
400000 USD
grbk Contributionsof Llc Members
ContributionsofLLCMembers
0 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
1505000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
527000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5251000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10993000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38879000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22554000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13164000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-523000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33269000 USD
CY2018Q4 us-gaap Cash
Cash
38315000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
4416000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
3440000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37685000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41755000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40269000 USD
CY2019Q3 us-gaap Cash
Cash
35123000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
10580000 USD
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
6109000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50849000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41232000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10181000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14313000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Basis of Presentation</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”), but do not include all of the information and footnotes required for complete financial statements. The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. In the opinion of management, the accompanying unaudited condensed consolidated financial statements for the periods presented reflect all adjustments of a normal, recurring nature necessary to fairly state our financial position, results of operations and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020 or subsequent periods due to seasonal variations and other factors, such as the effects of novel coronavirus (“COVID-19”) and its influence on our future results.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management of the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
us-gaap Reclassifications
Reclassifications
<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reclassifications</span></div><div style="padding-right:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2020, the Company reclassified the allowances for option deposits and pre-acquisition costs related to option contracts from selling, general and administrative expenses to other (loss) income, net in the consolidated statements of income to conform to current year presentation. There was no impact on net income from the reclassification in any period.</span></div>
CY2020Q3 grbk Finished Homesand Homesunder Construction
FinishedHomesandHomesunderConstruction
302070000 USD
CY2019Q4 grbk Finished Homesand Homesunder Construction
FinishedHomesandHomesunderConstruction
314966000 USD
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
470791000 USD
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
437553000 USD
CY2020Q3 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
6499000 USD
CY2019Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
1048000 USD
CY2020Q3 us-gaap Inventory Real Estate
InventoryRealEstate
779360000 USD
CY2019Q4 us-gaap Inventory Real Estate
InventoryRealEstate
753567000 USD
CY2020Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
18791000 USD
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
17199000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
18596000 USD
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
14780000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
2010000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
3052000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
7677000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
9066000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
2999000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
2324000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8471000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
5919000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
17802000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
17927000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
17802000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
17927000 USD
CY2020Q3 grbk Capitalized Interest As A Percentage Of Inventory
CapitalizedInterestAsAPercentageOfInventory
0.023
CY2019Q3 grbk Capitalized Interest As A Percentage Of Inventory
CapitalizedInterestAsAPercentageOfInventory
0.025
grbk Capitalized Interest As A Percentage Of Inventory
CapitalizedInterestAsAPercentageOfInventory
0.023
grbk Capitalized Interest As A Percentage Of Inventory
CapitalizedInterestAsAPercentageOfInventory
0.025
CY2020Q3 grbk Inventory With Potential Indicators Of Impairment
InventoryWithPotentialIndicatorsOfImpairment
8200000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0.0 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0.0 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0.1 USD
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1011000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1358000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
93489000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
164642000 USD
CY2020Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
27800000 USD
CY2019Q3 us-gaap Senior Notes
SeniorNotes
75000000.0 USD
CY2019Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0400
CY2019Q3 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
73300000 USD
CY2019Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
1500000 USD
CY2019Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
200000 USD
CY2020Q3 us-gaap Unsecured Debt
UnsecuredDebt
37500000 USD
CY2020Q3 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
37.4 USD
CY2019Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12485000 USD
CY2018Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12509000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
501000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
863000 USD
CY2020Q3 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
638000 USD
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1163000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
13624000 USD
CY2019Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12209000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
13611000 USD
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
8531000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1743000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
2528000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
1505000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
527000 USD
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
225000 USD
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1677000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
13624000 USD
CY2019Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12209000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
5300000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1500000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
400000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
75708 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
250000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
264000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
8.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.33
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
500000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
500000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y29D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4305000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
500000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y29D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4305000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000.0 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
400000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
400000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y8M12D
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29339000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23954000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7571000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8642000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
21562000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15998000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22100000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3669000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15510000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
61747000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2919000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22098000 USD
us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
Our contracts with homebuyers have a duration of less than one year. As such, the Company uses the practical expedient as allowed under ASC 606, Revenue from Contracts with Customers, and therefore has not disclosed the transaction price allocated to remaining performance obligations as of the end of the reporting period.
CY2020Q3 us-gaap Revenues
Revenues
275821000 USD
CY2019Q3 us-gaap Revenues
Revenues
209404000 USD
us-gaap Revenues
Revenues
721921000 USD
us-gaap Revenues
Revenues
561538000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
67886000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
44725000 USD
us-gaap Gross Profit
GrossProfit
170750000 USD
us-gaap Gross Profit
GrossProfit
120372000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45923000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24972000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104864000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5800000 USD
CY2020Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
779360000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
753567000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000000.0 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.166
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
7400000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34819000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15671000 USD
us-gaap Net Income Loss
NetIncomeLoss
84383000 USD
us-gaap Net Income Loss
NetIncomeLoss
42736000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50617000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50475000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50552000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50564000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50617000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50475000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50552000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50564000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
259000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
122000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
187000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
78000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50876000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50597000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50739000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50642000 shares
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000 shares
CY2020Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
120100000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
5267000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
5267000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
210000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
210000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 USD
CY2020Q3 grbk Contributionsof Llc Members
ContributionsofLLCMembers
0.0 USD
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
7200000 USD
CY2020Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
51000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
169000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-88000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
72000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
900000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
900000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
300000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
300000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
900000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
900000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
334000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1092000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
817000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1216000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
86000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
153000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3698000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
810000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2888000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD

Files In Submission

Name View Source Status
0001373670-20-000062-index-headers.html Edgar Link pending
0001373670-20-000062-index.html Edgar Link pending
0001373670-20-000062.txt Edgar Link pending
0001373670-20-000062-xbrl.zip Edgar Link pending
a1041notepurchaseagreeme.htm Edgar Link pending
a1041notepurchaseagreeme001.jpg Edgar Link pending
a1041notepurchaseagreeme002.jpg Edgar Link pending
a1041notepurchaseagreeme003.jpg Edgar Link pending
a1041notepurchaseagreeme004.jpg Edgar Link pending
a1041notepurchaseagreeme005.jpg Edgar Link pending
a1041notepurchaseagreeme006.jpg Edgar Link pending
a1041notepurchaseagreeme007.jpg Edgar Link pending
a1041notepurchaseagreeme008.jpg Edgar Link pending
a1041notepurchaseagreeme009.jpg Edgar Link pending
a1041notepurchaseagreeme010.jpg Edgar Link pending
a1041notepurchaseagreeme011.jpg Edgar Link pending
a1041notepurchaseagreeme012.jpg Edgar Link pending
a1041notepurchaseagreeme013.jpg Edgar Link pending
a1041notepurchaseagreeme014.jpg Edgar Link pending
a1041notepurchaseagreeme015.jpg Edgar Link pending
a1041notepurchaseagreeme016.jpg Edgar Link pending
a1041notepurchaseagreeme017.jpg Edgar Link pending
a1041notepurchaseagreeme018.jpg Edgar Link pending
a1041notepurchaseagreeme019.jpg Edgar Link pending
a1041notepurchaseagreeme020.jpg Edgar Link pending
a1041notepurchaseagreeme021.jpg Edgar Link pending
a1041notepurchaseagreeme022.jpg Edgar Link pending
a1041notepurchaseagreeme023.jpg Edgar Link pending
a1041notepurchaseagreeme024.jpg Edgar Link pending
a1041notepurchaseagreeme025.jpg Edgar Link pending
a1041notepurchaseagreeme026.jpg Edgar Link pending
a1041notepurchaseagreeme027.jpg Edgar Link pending
a1041notepurchaseagreeme028.jpg Edgar Link pending
a1041notepurchaseagreeme029.jpg Edgar Link pending
a1041notepurchaseagreeme030.jpg Edgar Link pending
a1041notepurchaseagreeme031.jpg Edgar Link pending
a1041notepurchaseagreeme032.jpg Edgar Link pending
a1041notepurchaseagreeme033.jpg Edgar Link pending
a1041notepurchaseagreeme034.jpg Edgar Link pending
a1041notepurchaseagreeme035.jpg Edgar Link pending
a1041notepurchaseagreeme036.jpg Edgar Link pending
a1041notepurchaseagreeme037.jpg Edgar Link pending
a1041notepurchaseagreeme038.jpg Edgar Link pending
a1041notepurchaseagreeme039.jpg Edgar Link pending
a1041notepurchaseagreeme040.jpg Edgar Link pending
a1041notepurchaseagreeme041.jpg Edgar Link pending
a1041notepurchaseagreeme042.jpg Edgar Link pending
a1041notepurchaseagreeme043.jpg Edgar Link pending
a1041notepurchaseagreeme044.jpg Edgar Link pending
a1041notepurchaseagreeme045.jpg Edgar Link pending
a1041notepurchaseagreeme046.jpg Edgar Link pending
a1041notepurchaseagreeme047.jpg Edgar Link pending
a1041notepurchaseagreeme048.jpg Edgar Link pending
a1041notepurchaseagreeme049.jpg Edgar Link pending
a1041notepurchaseagreeme050.jpg Edgar Link pending
a1041notepurchaseagreeme051.jpg Edgar Link pending
a1041notepurchaseagreeme052.jpg Edgar Link pending
a1041notepurchaseagreeme053.jpg Edgar Link pending
a1041notepurchaseagreeme054.jpg Edgar Link pending
a1041notepurchaseagreeme055.jpg Edgar Link pending
a1041notepurchaseagreeme056.jpg Edgar Link pending
a1041notepurchaseagreeme057.jpg Edgar Link pending
a1041notepurchaseagreeme058.jpg Edgar Link pending
a1041notepurchaseagreeme059.jpg Edgar Link pending
a1041notepurchaseagreeme060.jpg Edgar Link pending
a1041notepurchaseagreeme061.jpg Edgar Link pending
a1041notepurchaseagreeme062.jpg Edgar Link pending
a1041notepurchaseagreeme063.jpg Edgar Link pending
a1041notepurchaseagreeme064.jpg Edgar Link pending
a1041notepurchaseagreeme065.jpg Edgar Link pending
a1041notepurchaseagreeme066.jpg Edgar Link pending
a1041notepurchaseagreeme067.jpg Edgar Link pending
a1041notepurchaseagreeme068.jpg Edgar Link pending
a1041notepurchaseagreeme069.jpg Edgar Link pending
a1041notepurchaseagreeme070.jpg Edgar Link pending
a1041notepurchaseagreeme071.jpg Edgar Link pending
a1041notepurchaseagreeme072.jpg Edgar Link pending
a1041notepurchaseagreeme073.jpg Edgar Link pending
a1041notepurchaseagreeme074.jpg Edgar Link pending
a1041notepurchaseagreeme075.jpg Edgar Link pending
a1041notepurchaseagreeme076.jpg Edgar Link pending
a1041notepurchaseagreeme077.jpg Edgar Link pending
a1041notepurchaseagreeme078.jpg Edgar Link pending
a1041notepurchaseagreeme079.jpg Edgar Link pending
a1041notepurchaseagreeme080.jpg Edgar Link pending
a1041notepurchaseagreeme081.jpg Edgar Link pending
a1041notepurchaseagreeme082.jpg Edgar Link pending
a1041notepurchaseagreeme083.jpg Edgar Link pending
a1041notepurchaseagreeme084.jpg Edgar Link pending
a1041notepurchaseagreeme085.jpg Edgar Link pending
a1041notepurchaseagreeme086.jpg Edgar Link pending
a1041notepurchaseagreeme087.jpg Edgar Link pending
a1041notepurchaseagreeme088.jpg Edgar Link pending
a1041notepurchaseagreeme089.jpg Edgar Link pending
a1041notepurchaseagreeme090.jpg Edgar Link pending
a1041notepurchaseagreeme091.jpg Edgar Link pending
a1041notepurchaseagreeme092.jpg Edgar Link pending
a1041notepurchaseagreeme093.jpg Edgar Link pending
a1041notepurchaseagreeme094.jpg Edgar Link pending
a1041notepurchaseagreeme095.jpg Edgar Link pending
a1041notepurchaseagreeme096.jpg Edgar Link pending
a1041notepurchaseagreeme097.jpg Edgar Link pending
a1041notepurchaseagreeme098.jpg Edgar Link pending
a1041notepurchaseagreeme099.jpg Edgar Link pending
a1041notepurchaseagreeme100.jpg Edgar Link pending
a1041notepurchaseagreeme101.jpg Edgar Link pending
a1041notepurchaseagreeme102.jpg Edgar Link pending
a1041notepurchaseagreeme103.jpg Edgar Link pending
a1041notepurchaseagreeme104.jpg Edgar Link pending
a1041notepurchaseagreeme105.jpg Edgar Link pending
a1041notepurchaseagreeme106.jpg Edgar Link pending
a1041notepurchaseagreeme107.jpg Edgar Link pending
a1041notepurchaseagreeme108.jpg Edgar Link pending
a1041notepurchaseagreeme109.jpg Edgar Link pending
a1041notepurchaseagreeme110.jpg Edgar Link pending
a1042subsidiaryguarantya.htm Edgar Link pending
a1042subsidiaryguarantya001.jpg Edgar Link pending
a1042subsidiaryguarantya002.jpg Edgar Link pending
a1042subsidiaryguarantya003.jpg Edgar Link pending
a1042subsidiaryguarantya004.jpg Edgar Link pending
a1042subsidiaryguarantya005.jpg Edgar Link pending
a1042subsidiaryguarantya006.jpg Edgar Link pending
a1042subsidiaryguarantya007.jpg Edgar Link pending
a1042subsidiaryguarantya008.jpg Edgar Link pending
a1042subsidiaryguarantya009.jpg Edgar Link pending
a1042subsidiaryguarantya010.jpg Edgar Link pending
a1042subsidiaryguarantya011.jpg Edgar Link pending
a1042subsidiaryguarantya012.jpg Edgar Link pending
a1042subsidiaryguarantya013.jpg Edgar Link pending
a1042subsidiaryguarantya014.jpg Edgar Link pending
a1042subsidiaryguarantya015.jpg Edgar Link pending
a1042subsidiaryguarantya016.jpg Edgar Link pending
a1042subsidiaryguarantya017.jpg Edgar Link pending
a1042subsidiaryguarantya018.jpg Edgar Link pending
a1042subsidiaryguarantya019.jpg Edgar Link pending
a1042subsidiaryguarantya020.jpg Edgar Link pending
a1042subsidiaryguarantya021.jpg Edgar Link pending
a1042subsidiaryguarantya022.jpg Edgar Link pending
a1042subsidiaryguarantya023.jpg Edgar Link pending
a108adolsonemploymentcon.htm Edgar Link pending
a108adolsonemploymentcon001.jpg Edgar Link pending
a108adolsonemploymentcon002.jpg Edgar Link pending
a108adolsonemploymentcon003.jpg Edgar Link pending
a108adolsonemploymentcon004.jpg Edgar Link pending
a108adolsonemploymentcon005.jpg Edgar Link pending
a108adolsonemploymentcon006.jpg Edgar Link pending
a108adolsonemploymentcon007.jpg Edgar Link pending
a108adolsonemploymentcon008.jpg Edgar Link pending
a108adolsonemploymentcon009.jpg Edgar Link pending
a108adolsonemploymentcon010.jpg Edgar Link pending
a108adolsonemploymentcon011.jpg Edgar Link pending
a108adolsonemploymentcon012.jpg Edgar Link pending
a108adolsonemploymentcon013.jpg Edgar Link pending
a108adolsonemploymentcon014.jpg Edgar Link pending
exhibit311certificatio.htm Edgar Link pending
exhibit312certificatio.htm Edgar Link pending
exhibit321certificatio.htm Edgar Link pending
exhibit322certificatio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grbk-20200930.htm Edgar Link pending
grbk-20200930.xsd Edgar Link pending
grbk-20200930_cal.xml Edgar Link unprocessable
grbk-20200930_def.xml Edgar Link unprocessable
grbk-20200930_htm.xml Edgar Link completed
grbk-20200930_lab.xml Edgar Link unprocessable
grbk-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending